Sulfonic Acid Derivatives in the Production of Stable Co-Amorphous Systems for Solubility EnhancementJOURNAL OF PHARMACEUTICAL SCIENCESIF3.82022-12-015PRE
In Situ Co-Amorphization of Olanzapine in the Matrix and on the Coat of PelletsPHARMACEUTICSIF5.52022-11-240OAAI
The Precision and Accuracy of 3D Printing of Tablets by Fused Deposition ModellingJOURNAL OF PHARMACEUTICAL SCIENCESIF3.82022-10-019PRE
Downstream Processing of Amorphous and Co-Amorphous Olanzapine Powder BlendsPHARMACEUTICSIF5.52022-07-239OAAI
Comparison of the amorphization ability of two polymorphic forms of olanzapineANNALS OF MEDICINEIF4.32021-09-280OAAI
Assessment of the stability of co-amorphous olanzapine in tabletsANNALS OF MEDICINEIF4.32021-09-280OAAI
Measurement of the amorphous fraction of olanzapine incorporated in a co-amorphous formulationINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22020-10-0116PREAI
Drug-excipient and drug-drug mixtures: a pathway for the production of co-amorphous entitiesANNALS OF MEDICINEIF4.32019-05-282OAAI